Saliva Test for Endometriosis Gains Conditional Approval in France

The French health authority has approved a temporary financial coverage for a saliva-based diagnostic test for endometriosis, pending further clinical results.

The Haute Autorité de Santé (HAS) has endorsed a temporary financial coverage for the Endotest, a saliva test designed to diagnose endometriosis in women over 18.
The approval is part of an 'innovation' scheme allowing women with suspected endometriosis to access the test for free while participating in a clinical study.
Endotest has shown promising initial results, but more data is needed to determine its long-term efficacy and potential for widespread reimbursement.
The clinical study aims to include 2,500 participants across 80 centers, focusing on reducing unnecessary coelioscopies and improving diagnosis accuracy.
Endometriosis affects about one in ten women, often causing severe menstrual pain and fertility issues, with diagnosis typically delayed by an average of seven years.